Minerva Neurosciences's total assets for Q4 2024 were $37.14M, a decrease of -13.24% from the previous quarter. NERV total liabilities were $62.84M for the fiscal quarter, a -2.55% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.